OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30040555

Liaoning Kelong Fine Chemical Inc

Specialty ChemicalsVerified

Liaoning Kelong Fine Chemical Inc has a debt-to-equity ratio of 1.07, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.08, suggesting limited short-term liquidity cushion. Free cash flow is negative at -49.94 million CNY, and operating cash flow is 31.15 million CNY, indicating that the company is not generating sufficient cash from operations to cover capital expenditures. Profitability metrics are weak, with a return on equity of -11.13% and a return on assets of -4.74%, both significantly below the industry median for specialty chemicals. The company reported a net loss of 49.83 million CNY and an operating loss of 64.78 million CNY, reflecting poor operational performance and cost management. The company operates as a single business segment, with no disclosed geographic diversification. Revenue is concentrated in one operating segment, and there is no information on geographic revenue distribution. This lack of diversification increases exposure to regional economic or regulatory risks. Growth prospects are constrained, with no disclosed revenue growth in the most recent period. The company reported a revenue of 632.20 million CNY, but this is not sufficient to offset operating losses. There is no indication of a clear growth strategy or expansion into new markets. The company faces moderate liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance or at-the-market (ATM) programs. However, the company's negative free cash flow and operating losses may pressure the need for additional financing in the future. Recent filings and transcripts do not indicate any major strategic shifts or operational overhauls. The company has not disclosed any material events or regulatory actions in the latest available data. There is no indication of significant capital restructuring or new product launches.

30-day price · 300405(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyLiaoning Kelong Fine Chemical Inc
Ticker300405.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Liaoning Kelong Fine Chemical Inc is a specialty chemicals company that produces and sells fine chemical products, primarily used in the pharmaceutical and agrochemical industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Liaoning Kelong Fine Chemical Inc has a debt-to-equity ratio of 1.07, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.08, suggesting limited short-term liquidity cushion. Free cash flow is negative at -49.94 million CNY, and operating cash flow is 31.15 million CNY, indicating that the company is not generating sufficient cash from operations to cover capital expenditures. Profitability metrics are weak, with a return on equity of -11.13% and a return on assets of -4.74%, both significantly below the industry median for specialty chemicals. The company reported a net loss of 49.83 million CNY and an operating loss of 64.78 million CNY, reflecting poor operational performance and cost management. The company operates as a single business segment, with no disclosed geographic diversification. Revenue is concentrated in one operating segment, and there is no information on geographic revenue distribution. This lack of diversification increases exposure to regional economic or regulatory risks. Growth prospects are constrained, with no disclosed revenue growth in the most recent period. The company reported a revenue of 632.20 million CNY, but this is not sufficient to offset operating losses. There is no indication of a clear growth strategy or expansion into new markets. The company faces moderate liquidity risk due to negative net cash after subtracting total debt. Dilution risk is assessed as low, with no recent or disclosed share issuance or at-the-market (ATM) programs. However, the company's negative free cash flow and operating losses may pressure the need for additional financing in the future. Recent filings and transcripts do not indicate any major strategic shifts or operational overhauls. The company has not disclosed any material events or regulatory actions in the latest available data. There is no indication of significant capital restructuring or new product launches.
Key takeaways
  • The company is operating at a net loss and has negative free cash flow, indicating poor financial health.
  • Return on equity and return on assets are significantly below industry medians, reflecting weak profitability.
  • The company has a moderate debt load and limited liquidity, increasing financial risk.
  • There is no geographic or segment diversification, increasing exposure to regional and operational risks.
  • No recent strategic or operational developments have been disclosed, suggesting a lack of momentum.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$632.2M
Gross profit$44.4M
Operating income-$64.8M
Net income-$49.8M
R&D
SG&A
D&A
SBC
Operating cash flow$31.2M
CapEx-$12.1M
Free cash flow-$49.9M
Total assets$1.05B
Total liabilities$602.5M
Total equity$447.8M
Cash & equivalents
Long-term debt$477.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$447.8M
Net cash-$477.7M
Current ratio1.1
Debt/Equity1.1
ROA-4.7%
ROE-11.1%
Cash conversion-63.0%
CapEx/Revenue-1.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300405Activity
Op margin-10.2%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-7.9%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin7.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity107.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 02:56 UTCJob: dcdd53ac